Wiseman P A, Malone-Lee J, Rai G S
Department of Geriatric Medicine, University College and Middlesex School of Medicine, University College Hospital, London.
BMJ. 1991 Apr 27;302(6783):994-6. doi: 10.1136/bmj.302.6783.994.
To compare terodiline with bladder retraining against placebo with bladder retraining in the treatment of detrusor instability in frail elderly patients.
Randomised, double blind, parallel group study. Treatment lasted for six weeks. Frequency of micturition and episodes of incontinence recorded on diary chart by patients.
Incontinence clinic and a geriatric day hospital at two teaching hospitals.
37 frail but ambulant patients, mean (range) age 80.4 (70-89) years with urinary frequency and urge incontinence, due to detrusor instability. Two patients withdrew before the first assessment (one in each group) and one could not complete the diary chart (placebo group).
19 patients received bladder retraining and terodiline 25 mg daily and 18 bladder retraining and placebo.
Change in urinary frequency and number of episodes of incontinence after six weeks' treatment. Patient's subjective evaluation of symptoms.
Little difference was found in the results of treatment with terodiline and placebo. The change in episodes of incontinence per 24 hours was no different in the two groups (95% confidence interval -0.6 to 1.2; p = 0.75) and the difference between treatments in the change in frequency of micturition per 24 hours (-0.2) was not significant (-1.1 to 1.2; p = 0.76). Ten patients taking terodiline thought they had improved compared with seven receiving placebo; this difference was not significant.
Although the number of patients in each group was small and may have been insufficient to detect a drug effect, the possible benefit of terodiline is likely to be small.
比较曲地氯铵联合膀胱再训练与安慰剂联合膀胱再训练治疗体弱老年患者逼尿肌不稳定的疗效。
随机、双盲、平行组研究。治疗持续6周。患者通过日记表记录排尿频率和尿失禁发作情况。
两家教学医院的尿失禁诊所和老年日间医院。
37例体弱但能行走的患者,平均(范围)年龄80.4(70 - 89)岁,因逼尿肌不稳定出现尿频和急迫性尿失禁。两名患者在首次评估前退出(每组各1例),一名患者无法完成日记表(安慰剂组)。
19例患者接受膀胱再训练并每日服用25 mg曲地氯铵,18例患者接受膀胱再训练并服用安慰剂。
治疗6周后尿频和尿失禁发作次数的变化。患者对症状的主观评估。
曲地氯铵和安慰剂治疗结果差异不大。两组每24小时尿失禁发作次数的变化无差异(95%置信区间 -0.6至1.2;p = 0.75),两种治疗方法每24小时排尿频率变化的差异(-0.2)不显著(-1.1至1.2;p = 0.76)。10例服用曲地氯铵的患者认为病情有所改善,而服用安慰剂的患者有7例,差异不显著。
尽管每组患者数量较少,可能不足以检测出药物疗效,但曲地氯铵可能带来的益处可能很小。